Trial intelligence / Profile preview

Prulifloxacin vs ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy

2005-002888-88Phase 2Terminated

Sponsor
Angelini Pharma
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of prulifloxacin in infection prophylaxis and postprocedural infection (SSI) (3 arms), sponsored by Angelini Pharma. Started Jan 2007; status: terminated.

02

Drugs

prulifloxacin
03

Conditions

infection prophylaxispostprocedural infection (SSI)

Beyond the preview

Go deeper on 2005-002888-88.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002888-88.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call